Catalyst Capital Advisors LLC Buys 235 Shares of Xylem Inc. (NYSE:XYL)

Catalyst Capital Advisors LLC boosted its stake in shares of Xylem Inc. (NYSE:XYL) by 226.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 339 shares of the industrial products company’s stock after purchasing an additional 235 shares during the quarter. Catalyst Capital Advisors LLC’s holdings in Xylem were worth $46,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Hazlett Burt & Watson Inc. raised its stake in shares of Xylem by 92.4% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 656 shares of the industrial products company’s stock worth $88,000 after acquiring an additional 315 shares in the last quarter. Impax Asset Management Group plc increased its position in shares of Xylem by 1.0% during the third quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company’s stock worth $226,555,000 after purchasing an additional 15,825 shares in the last quarter. Quintet Private Bank Europe S.A. lifted its holdings in shares of Xylem by 28.0% during the 3rd quarter. Quintet Private Bank Europe S.A. now owns 203,262 shares of the industrial products company’s stock valued at $27,446,000 after purchasing an additional 44,414 shares during the last quarter. QRG Capital Management Inc. boosted its position in shares of Xylem by 12.2% in the 3rd quarter. QRG Capital Management Inc. now owns 15,281 shares of the industrial products company’s stock worth $2,063,000 after purchasing an additional 1,665 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. grew its stake in Xylem by 27.1% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 314,964 shares of the industrial products company’s stock worth $42,530,000 after buying an additional 67,061 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

Shares of XYL opened at $123.73 on Thursday. The business’s 50-day moving average is $132.21 and its two-hundred day moving average is $135.16. The company has a market capitalization of $30.06 billion, a P/E ratio of 36.18, a P/E/G ratio of 2.23 and a beta of 1.05. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.42 and a current ratio of 1.96. Xylem Inc. has a fifty-two week low of $95.35 and a fifty-two week high of $146.08.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, hitting the consensus estimate of $1.11. The company had revenue of $2.10 billion for the quarter, compared to the consensus estimate of $2.17 billion. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The firm’s revenue for the quarter was up .2% compared to the same quarter last year. During the same period last year, the firm earned $0.99 EPS. Research analysts predict that Xylem Inc. will post 4.23 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 26th. Shareholders of record on Thursday, August 29th were given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 1.16%. The ex-dividend date was Thursday, August 29th. Xylem’s dividend payout ratio is currently 42.11%.

Analyst Ratings Changes

XYL has been the subject of a number of research analyst reports. Robert W. Baird decreased their price target on Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. TD Cowen lowered their target price on shares of Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a research note on Wednesday. Royal Bank of Canada cut their price target on shares of Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Stifel Nicolaus lifted their price objective on shares of Xylem from $170.00 to $172.00 and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Finally, UBS Group initiated coverage on shares of Xylem in a report on Tuesday, August 13th. They set a “buy” rating and a $165.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and an average target price of $147.17.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.